Zai Lab unveils early lung cancer data as it looks to challenge Amgen’s Imdelltra

Zai Lab re­leased Phase 1a da­ta Thurs­day morn­ing as it at­tempts to com­pete with a re­cent­ly ap­proved Am­gen drug.

The pro­gram, known as ZL-1310, in­duced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.